What is measurable residual disease MRD and why is it important in ALL?

During the ESH 3rd How to Diagnose and Treat Acute Leukaemias Know ALL spoke with Sebastian Giebel Maria Sklodowska-Curie National Research Institute of Oncology Gliwice PL.
We asked What is measurable residual disease MRD and why is it important in ALL? Giebel begins by discussing detection methods including flow cytometry or molecular techniques which are used to precisely monitor responses.
He highlights the huge prognostic impact MRD can have for patients.
Finally he outlines the bispecific antibody blinatumomab used as a therapy to eradicate MRD.

Источник: rutube.ru